Changeflow GovPing Pharma & Drug Safety EP4200339A2 - Compositions and Methods Related ...
Routine Notice Added Final

EP4200339A2 - Compositions and Methods Related to Receptor Pairings

Favicon for changeflow.com EPO Patent Bulletin - Peptides (C07K)
Published
Detected
Email

Summary

European Patent Office granted Patent EP4200339A2 to Synthekine, Inc. covering compositions and methods related to receptor pairings. The patent application, filed with IPC classifications C07K 16/28, C07K 14/715, and C07K 14/705, lists inventors KASTELEIN Robert, LUPARDUS Patrick J., and ROKKAM Deepti. The patent is designated across all European member states.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

EPO granted Patent EP4200339A2 to Synthekine, Inc. for compositions and methods related to receptor pairings, specifically classified under C07K peptide chemistry with applications in immunological therapeutics. The patent covers novel receptor pairing configurations and associated composition claims.

Affected parties include biotechnology and pharmaceutical companies engaged in cytokine engineering, immunocytokine development, and receptor-targeted therapeutic research. Competitors in this space should review the patent claims to assess freedom-to-operate considerations for their own research programs and product development activities.

Archived snapshot

Apr 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

COMPOSITIONS AND METHODS RELATED TO RECEPTOR PAIRINGS

Publication EP4200339A2 Kind: A2 Apr 08, 2026

Applicants

Synthekine, Inc.

Inventors

KASTELEIN, Robert, LUPARDUS, Patrick J., ROKKAM, Deepti

IPC Classifications

C07K 16/28 20060101AFI20250326BHEP C07K 14/715 20060101ALI20250326BHEP C07K 14/705 20060101ALI20250326BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4200339A2

Who this affects

Applies to
Drug manufacturers Healthcare providers Investors
Industry sector
3254.1 Biotechnology
Activity scope
Patent grant IP portfolio Biotech research
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare Biotechnology

Get alerts for this source

We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!